Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Concentrix Corp’s stock clocked out at $59.97, down -0.88% from its previous closing price of $60.5. In other words, the price has decreased by -$0.88 from its previous closing price. On the day, 0.66 million shares were traded. CNXC stock price reached its highest trading level at $61.0826 during the session, while it also had its lowest trading level at $58.65.
Ratios:
To gain a deeper understanding of CNXC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.79. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 08 ’25 when Olivier Fabrice Duha bought 300,000 shares for $60.50 per share.
Twomey Cormac J sold 500 shares of CNXC for $26,280 on Jun 30 ’25. The EVP, Global Ops & Delivery now owns 37,630 shares after completing the transaction at $52.56 per share. On Jun 30 ’25, another insider, CORMAC TWOMEY, who serves as the Officer of the company, bought 500 shares for $52.56 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 3779615232 and an Enterprise Value of 8844748800. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.47, and their Forward P/E ratio for the next fiscal year is 4.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 0.919 whereas that against EBITDA is 6.181.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.58, which has changed by -0.12682003 over the last 52 weeks, in comparison to a change of 0.12153554 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $77.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of the stock is 9.44%, while the 200-Day Moving Average is calculated to be 22.21%.
Shares Statistics:
It appears that CNXC traded 702.15K shares on average per day over the past three months and 1117970 shares per day over the past ten days. A total of 62.93M shares are outstanding, with a floating share count of 44.65M. Insiders hold about 29.15% of the company’s shares, while institutions hold 80.81% stake in the company. Shares short for CNXC as of 1749772800 were 6149671 with a Short Ratio of 8.76, compared to 1747267200 on 5801928. Therefore, it implies a Short% of Shares Outstanding of 6149671 and a Short% of Float of 11.55.
Dividends & Splits
With its trailing 12-month dividend rate of 1.301, CNXC has a forward annual dividend rate of 1.30. Against a Trailing Annual Dividend Yield of 0.021504132
Earnings Estimates
Concentrix Corp (CNXC) is presently subject to a detailed evaluation by 5.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $3.26, with high estimates of $3.32 and low estimates of $3.11.
Analysts are recommending an EPS of between $11.7 and $11.56 for the fiscal current year, implying an average EPS of $11.63. EPS for the following year is $12.45, with 6.0 analysts recommending between $12.81 and $11.92.
Revenue Estimates
In the current quarter, 4 analysts expect revenue to total $2.46B. It ranges from a high estimate of $2.47B to a low estimate of $2.45B. As of the current estimate, Concentrix Corp’s year-ago sales were $2.39BFor the next quarter, 4 analysts are estimating revenue of $2.53B. There is a high estimate of $2.55B for the next quarter, whereas the lowest estimate is $2.49B.
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $9.81B, while the lowest revenue estimate was $9.73B, resulting in an average revenue estimate of $9.77B. In the same quarter a year ago, actual revenue was $9.62BBased on 5 analysts’ estimates, the company’s revenue will be $10.06B in the next fiscal year. The high estimate is $10.17B and the low estimate is $9.9B.
